Revised: 3 May 2019
Information for Healthcare Professionals
This section provides information useful to healthcare professionals.
ADR eLearning Module
Endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for around 1.0 hours CME for General Practice Educational Programme 2/3 (GPEP) and Continuing Professional Development (CPD) purposes.
Medsafe Advice
| Date | Type | Title |
|---|---|---|
| 15/07/2019 | Committees | Agenda for the 63rd Medicines Classification Committee Meeting |
| 11/07/2019 | Consultation | Changes to the prescribing restrictions for riluzole |
| 10/07/2019 | Consultation | Medicinal Cannabis Scheme consultation Closes 7 Aug 2019 |
| 28/06/2019 | Publications | Consumer Information Leaflet - Taking Lithium during pregnancy (PDF 319 KB, 2 pages) |
| 27/06/2019 | Consultation | Proposed warning statements for substances (eg, allergens) in medicines that may cause undesirable reactions |
| 25/06/2019 | Committees | Reclassification of Melatonin |
| 11/06/2019 | Alert Communication | Xiaflex® (collagenase clostridium histolyticum) product discontinuation from 28 June 2019 (PDF 231 KB, 2 pages) |
| 7/06/2019 | Publications | Prescriber Update 40(2) June 2019 |
| 7/06/2019 | Committees | Minutes of the 62nd meeting of the Medicines Classification Committee - 11 April 2019 |
| 30/05/2019 | Alert Communication | Update - Take care when prescribing and dispensing levodopa-containing products (Madopar, Sinemet, Kinson, Mylan) |
If you have an enquiry that is not answered by the information on the web site please contact us at askmedsafe@moh.govt.nz.
